The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Rosetta Inpharmatics, Inc.

Rosetta Inpharmatics, Inc.
 NEWS FROM THE STANDARD
Designer Drugs
May 21 2001 12:00 AM PDT

Merck to Buy Rosetta Inpharmatics
May 11 2001 05:35 PM PDT

 PROFILE
Rosetta Inpharmatics doesn't provide clues to reading hieroglyphics. It makes bioinformatics equipment and software that analyzes genetic information to identify gene functions and drug targets. Products include the Resolver Expression Data Analysis System, which stores and analyzes gene expression data; FlexJet DNA microarrays, glass slides containing DNA sequences; and software libraries of various cell responses to genetic diseases and treatments. It has an alliance with Agilent Technologies to make and market its products; the partnership accounts for almost half of Rosetta's revenues. Merck bought the company in 2001.

 COMPETITION
Affymetrix, Inc. (AFFX)
Applied Biosystems Group (ABI)
Incyte Genomics, Inc. (INCY)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 10.50
1-Yr. Sales Growth: 969.2%
Employees: 175
Revenue per employee: $60,000.00

 CONTACT INFO
12040 115th Ave. N.E.
Kirkland, WA 98034
US
Phone: 425-820-8900
Fax: 425-821-5354
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001